Cite
MLA Citation
Sahra Ali et al.. “European Medicines Agency extension of indication to include the combination immunotherapy cancer drug treatment with nivolumab (Opdivo) and ipilimumab (Yervoy) for adults with intermediate/poor-risk advanced renal cell carcinoma.” ESMO open, vol. 5, no. 6, 2020, p. . http://access.bl.uk/ark:/81055/vdc_100127560955.0x000015